Paper32899720
Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery.
González-Mora A and 4 others. Vaccines (Basel), 2020. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery. Papers, record 32899720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32899720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16556264 | Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. | Immunology | 2006 | https://conductscience.org/library/papers/16556264 | PubMed |
| 2 | 28622860 | Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV). | Vet Microbiol | 2017 | https://conductscience.org/library/papers/28622860 | PubMed |
| 3 | 30445702 | DNA Vaccines-How Far From Clinical Use? | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30445702 | PubMed |
| 4 | 29115536 | Advances in the T7 phage display system (Review). | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29115536 | PubMed |
| 5 | 20459865 | Recombinant lambda-phage nanobioparticles for tumor therapy in mice models. | Genet Vaccines Ther | 2010 | https://conductscience.org/library/papers/20459865 | PubMed |
| 6 | 16029917 | The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. | Vaccine | 2005 | https://conductscience.org/library/papers/16029917 | PubMed |
| 7 | 22015270 | Synthetic peptide-targeted selection of phage display mimotopes highlights immunogenic features of α-helical vs non-helical epitopes of Taenia solium paramyosin: implications for parasite- and host-protective roles of the protein. | Peptides | 2012 | https://conductscience.org/library/papers/22015270 | PubMed |
| 8 | 20223256 | Rapid isolation of single-chain antibodies by phage display technology directed against one of the most potent marine toxins: Palytoxin. | Toxicon | 2010 | https://conductscience.org/library/papers/20223256 | PubMed |
| 9 | 12559780 | Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization. | Vaccine | 2003 | https://conductscience.org/library/papers/12559780 | PubMed |
| 10 | 23029232 | Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge. | PLoS One | 2012 | https://conductscience.org/library/papers/23029232 | PubMed |
| 11 | 10725197 | Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2. | Virology | 2000 | https://conductscience.org/library/papers/10725197 | PubMed |
| 12 | 23251631 | Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide. | PLoS One | 2012 | https://conductscience.org/library/papers/23251631 | PubMed |
| 13 | 22210400 | Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine. | Vaccine | 2012 | https://conductscience.org/library/papers/22210400 | PubMed |
| 14 | 24442507 | Bacteriophage lambda display systems: developments and applications. | Appl Microbiol Biotechnol | 2014 | https://conductscience.org/library/papers/24442507 | PubMed |
| 15 | 29038472 | Phage-assisted continuous evolution of proteases with altered substrate specificity. | Nat Commun | 2017 | https://conductscience.org/library/papers/29038472 | PubMed |
| 16 | 22906939 | Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications. | Hum Vaccin Immunother | 2012 | https://conductscience.org/library/papers/22906939 | PubMed |
| 17 | 22334867 | Pros and cons of phage therapy. | Bacteriophage | 2011 | https://conductscience.org/library/papers/22334867 | PubMed |
| 18 | 18602466 | Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier. | Eur J Pharm Biopharm | 2008 | https://conductscience.org/library/papers/18602466 | PubMed |
| 19 | 19417736 | Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface. | Acta Pharmacol Sin | 2009 | https://conductscience.org/library/papers/19417736 | PubMed |
| 20 | 20056188 | Engineering filamentous phage carriers to improve focusing of antibody responses against peptides. | Vaccine | 2010 | https://conductscience.org/library/papers/20056188 | PubMed |
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931398 | Phage-Based Vaccine Platforms for Typhoid Fever: A Transformative Approach to Global Health and Antimicrobial Resistance. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931398 | PubMed |
| 42784001 | SgtrCypB Formulated with Freund's Adjuvant Confers Protective Immunity Against S. globosa and Partial Cross-Protection Against S. schenckii Infections in Mice. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42784001 | PubMed |
| 42621610 | Application of bacteriophages in the prevention and control of bacterial infectious diseases in animals. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42621610 | PubMed |
| 42164670 | Phage enabled precision drug delivery: dual function platforms for therapeutics and genetic cargo transport. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42164670 | PubMed |
| 41901734 | Cattle Immunization with T7 Phage-Displayed Whole-Tick Antigens Reduces Amblyomma americanum Feeding Efficiency and Blocks Larval Tick Hatching. | Pathogens | 2026 | https://conductscience.org/library/papers/41901734 | PubMed |
| 41893819 | Lambda Phage-Based Antibody-Stimulating Platform Targeting EGFRvIII. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893819 | PubMed |
| 41869406 | Filamentous Phage for Therapeutic Applications in Non-Small Cell Lung Cancer and Brain Metastases: Recent Prospect. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41869406 | PubMed |
| 41814421 | Host immunogenetic variation and gut microbiome functionality in a wild vertebrate population. | Microbiome | 2026 | https://conductscience.org/library/papers/41814421 | PubMed |
| 41401934 | Bacteriophages as vaccine platforms: Opportunities and challenges in translation. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/41401934 | PubMed |
| 41305429 | Potential Vaccine or Antimicrobial Reagents: Simple Systems for Producing Lambda Display Particles (LDP) and Sheathed Lambda DNA Vaccine Particles (LDNAP). | Viruses | 2025 | https://conductscience.org/library/papers/41305429 | PubMed |
| 41288714 | Emerging microbiome-directed therapies in inflammatory bowel disease: beyond diet modification and FMT. | Semin Immunopathol | 2025 | https://conductscience.org/library/papers/41288714 | PubMed |
| 41179940 | Bacteriophage-based therapies in oral cancer: A new frontier in oncology. | Cancer Pathog Ther | 2025 | https://conductscience.org/library/papers/41179940 | PubMed |
| 41025596 | Engineered bacteriophages for therapeutic and diagnostic applications. | Dis Model Mech | 2025 | https://conductscience.org/library/papers/41025596 | PubMed |
| 41012191 | Advances in Biotechnology and the Development of Novel Human Vaccines. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012191 | PubMed |
| 41012101 | Role of the Virome in Vaccine-Induced Immunization. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012101 | PubMed |
| 40963058 | Phage therapy and its role in cancer treatment and control. | Folia Microbiol (Praha) | 2025 | https://conductscience.org/library/papers/40963058 | PubMed |
| 40596331 | Engineering M13 bacteriophage to display HER2 mimotopes on pVIII for vaccine development. | Sci Rep | 2025 | https://conductscience.org/library/papers/40596331 | PubMed |
| 40563507 | Current Efficacy of Multiepitope Vaccines Against Helminths: A Systematic Review. | Biomolecules | 2025 | https://conductscience.org/library/papers/40563507 | PubMed |
| 40442309 | A virus based vaccine combined with IL12 gene therapy eradicates aggressive melanoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/40442309 | PubMed |
| 40430931 | Advances in the Functionalization of Vaccine Delivery Systems: Innovative Strategies and Translational Perspectives. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40430931 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32899720
GET https://conductscience.org/api/papers/v1/32899720/references?page=2